Pfizer (NYSE: PFE) underperformed the S&P 500 in 2020. And in 2019. And in 2017. And in 2016. You probably noticed I skipped 2018 — that was the only year in the past five when the big drugmaker managed to beat the broad-market index. If looking at historic returns was the bRead MoreMarketsMarkets Feed
¡Haz clic para votar esta entrada!
(Votos: 0 Promedio: 0)